MEASURING INTRAMUSCULAR FAT
20230306594 · 2023-09-28
Inventors
Cpc classification
G06T11/008
PHYSICS
International classification
Abstract
Dual-energy absorptiometry is used to estimate intramuscular adipose tissue metrics and display results, preferably as related to normative data. The process involves deriving x-ray measurements for respective pixel positions related to a two-dimensional projection image of a body slice containing intramuscular adipose tissue as well as subcutaneous adipose tissue, at least some of the measurements being dual-energy x-ray measurements, processing the measurements to derive estimates of metrics related to the intramuscular adipose tissue in the slice, and using the resulting estimates. Processing the measurements includes an algorithm which places boundaries of regions, e.g., a large region and a smaller region. The regions are combined in an equation that is highly correlated with intramuscular adipose tissue measured by quantitative computed tomography in order to estimate intramuscular adipose tissue.
Claims
1-28. (canceled)
29. A method of diagnosing sarcopenia in a subject, the method comprising: acquiring x-ray measurements for respective pixel positions of a two-dimensional projection image of a portion of the subject, wherein at least some of the measurements are dual-energy x-ray measurements; identifying a plurality of regions of the image; combining the plurality of regions to determine an estimate of intramuscular adipose tissue; comparing the determined estimate of intramuscular adipose tissue over a period of time for the subject; and diagnosing sarcopenia in the subject based on the comparison.
30. The method of claim 29, wherein sarcopenia is diagnosed when the determined estimate of intramuscular adipose tissue increases over the period of time.
31. The method of claim 29, wherein the identifying the plurality of regions comprises automatically identifying a larger region of the image and a smaller region of the image, the smaller region of the image disposed within the larger region of the image, wherein the acquiring x-ray measurements comprises acquiring x-ray measurements for pixel positions related to the larger and smaller regions.
32. The method of claim 31, wherein combining the plurality of regions comprises combining the x-ray measurements acquired for the pixel positions related to the larger and smaller regions.
33. The method of claim 31, wherein each of the larger region and the smaller region has left and right boundaries and wherein identifying the plurality of regions comprise identifying the left and right boundaries of the smaller region based on percent fat profile data corresponding to pixel positions from inside the left and right boundaries of the larger region moving toward a center of the larger region.
34. The method of claim 31, further comprising combining the acquired x-ray measurements in a linear equation using constants that provide correlation between dual-energy x-ray measured intramuscular adipose tissue and intramuscular adipose tissue measured by computed tomography.
35. The method of claim 34, wherein combining the acquired x-ray measurements comprises combining the x-ray measurements using polynomial expansion.
36. The method of claim 31, wherein the larger region of the image extends from a first side of a limb to a second side of the limb and wherein the smaller region extends across a muscle area from a first side to a second side between outermost extents of muscle wall.
37. The method of claim 31, wherein the larger region of the image extends from a first side of a limb to a second side of the limb and wherein the smaller region extends across a muscle area from a first side to a second side between outermost extents of muscle wall but is exclusive of a third region which is identified where bone is present and percent fat cannot be directly measured.
38. The method of claim 29, wherein identifying the plurality of regions of the image comprises using at least some of the x-ray measurements for identifying at least one region of the image.
39. The method of claim 31, wherein identifying the plurality of regions of the image comprises using an anatomical landmark and a preselected region of interest line to identify the larger region of the image.
40. The method of claim 31, wherein identifying the plurality of regions of the image comprises using at least some of the x-ray measurements for identifying the smaller region of the image.
41. The method of claim 36, further comprising identifying a left muscle wall and a right muscle wall by identifying inflection of adipose tissue values for identifying the smaller region of the image.
42. The method of claim 31, further comprising providing an estimate of intramuscular adipose tissue by processing the larger and smaller regions, wherein processing the larger and smaller regions comprises correlating the acquired x-ray measurements combined in a linear equation with intramuscular adipose tissue measured by quantitative computed tomography.
43. The method of claim 42, further comprising calculating the intramuscular adipose tissue as: J*muscle region adipose mass−K*(limb adipose mass−muscle region adipose mass)+b.
44. The method of claim 43, wherein constants J and K provide a correlation between dual-energy x-ray absorptiometry (DXA) intramuscular adipose tissue and intramuscular adipose tissue measured by computed tomography, and wherein b is an intercept.
45. The method of claim 43, further comprising selecting a value for at least one of J, K and b for the subject.
46. The method of claim 45, wherein selecting the value for at least one of J, K and b is based on at least one of age, gender, ethnicity, weight, height, body mass index, waist circumference, and other anthropomorphic variables of the subject.
47. The method as claimed in claim 31, wherein identifying the smaller region comprises automatically identifying the smaller region using % fat inflection.
48. The method as claimed in claim 31, wherein: each of the larger region and the smaller region has upper and lower boundaries; and the method further comprises superimposing the upper and lower boundaries of the smaller region over the upper and lower boundaries of the larger region.
49. The method as claimed in claim 33, further comprising setting each of the left and right boundaries of the smaller region at an inflection point by identifying % fat values of two consecutive pixels lower than a preceding pixel.
Description
BRIEF DESCRIPTION OF THE FIGURES
[0009]
[0010]
[0011]
[0012]
[0013]
[0014]
[0015]
DETAILED DESCRIPTION
[0016] Referring to
[0017]
[0018]
[0019] Referring to
[0020] Referring to
[0021] Regardless of how the boundaries which define the regions are placed, a linear regression technique that accounts for SAT between the boundaries of the larger region is used to estimate intramuscular adipose tissue. The large region defined by boundaries 306, 308, 310, 312 provides a measurement of total adipose tissue in a 5 cm wide region across the entire width of the subject's limb. The smaller region defined by boundaries 304, 301, 306, 308 provides a measurement of the adipose tissue in the same 5 cm wide region of the limb plus whatever subcutaneous fat is present above (at region 320) and below (at region 322) the muscle region in the two dimensional DXA projection. Constant percent fat values at the center of the plot in
DXA IAT=J*muscle region adipose mass−K*(limb adipose mass−muscle region adipose mass)+b. Eq. 1
where J and K are constants that optimize the correlation between DXA IAT and intramuscular adipose tissue measured by computed, tomography, and b is the intercept term of the linear equation. It should be noted that the values of J, K and b are not necessarily that same for all subjects. For example, values of J, K and b can be dependent upon age, gender, ethnicity, weight, height, body mass index, waist circumference, and other anthropomorphic variables. Those skilled in the art will understand how to determine those constants in view, of this disclosure.
[0022] The results of the processes described above can be in various forms and, can be used for a variety of purposes. For example, displays of numerical values can be used in assessing the health, treatment options, or treatments of a patient by a health professional. As another example, such numerical values or estimates derived therefrom can be used as inputs to automated systems for similar assessment or for treatment planning. As yet another example, parameters related to fat metrics can be displayed and recorded or printed as a part of an otherwise typical report including x-ray images and other DXA-produced information for a patient.
[0023] Estimates of intramuscular adipose tissue derived as discussed above can be shown in a variety of ways. They can be displayed alone, or in combination with known or expected ranges of comparable estimates for populations believed to be “normal” or “healthy,” which ranges can be matched to the estimates for a patient by some characteristic such as age, sex, and/or ethnicity. The normal or healthy ranges for such characteristics can be obtained by retrospective analysis of already completed studies and/or from new studies to obtain the data. An intramuscular adipose tissue metric for a patient can be compared with an intramuscular adipose tissue metric for the same patient taken at a different time to estimate the change and/or the rate of change, for example to see if visceral fat parameters have improved or have deteriorated over some period of time or in relation to some treatment or regimen. Such changes also can be matched to expected or known or estimated ranges to see if the change or rate of change for a patient is statistically significant as distinguished from a change within the precision range of the estimate. The intramuscular adipose tissue estimates derived as discussed above, or metrics based on such estimates, can be used in other ways as well. Ono non-limiting example is to produce reports similar to those produced for BMD (bone mineral density) in current commercial bone densitometry (DXA) systems hut for metrics of intramuscular adipose tissue rather than BMD estimates.
[0024]
[0025]
DXA IAT=J*Region1+K*Region2+L*Region3+b. Eq. 2
where J, K and L are constants (which may differ from those of Eq. 1) that optimize the correlation between DXA IAT and intramuscular adipose tissue measured by computed tomography, and b is the intercept term of the Linear equation. As in the previously described embodiment, the values of the constants (here J, K, and L) and intercept b are net necessarily that same for all subjects. For example, values of J, K, L and b can be dependent upon age, gender, ethnicity, weight, height, body mass index, waist circumference, and other anthropomorphic variables. Those skilled in the art will understand how to determine those constants in view of this disclosure. Furthermore, the two region and three region embodiments are merely exemplary, and any number regions could be defined and utilized to estimate IAT.
[0026] In an alternative embodiment polynomial expansion is used to estimate intramuscular adipose tissue. A generalized equation for combining the measurements of adipose tissue using polynomial expansion in order to estimate intramuscular adipose tissue (IAT) can be represented as:
DXA IAT=J1(Region1)+J2(Region1).sup.2+J3(Region1).sup.3+ . . . , Eq. 3
where Jn and constants associated with the polynomial expansion of the other regions (eg. K.sub.n and L.sub.n) optimize the correlation between DXA IAT and intramuscular adipose tissue measured by computed tomography. As in the previously described embodiment, the values the constants are not necessarily the same for all subjects, and can be dependent upon of gender, ethnicity, weight, height, body mass index, waist circumference, and other anthropomorphic variables.
[0027] The disclosure above is mainly in terms of SAT and intramuscular adipose tissue of human patients, but it should be clear that the approach is applicable in other fields as well, such as in analysis of other subjects, such as live animals and carcasses. Finally, while a currently preferred embodiment has been described in detail above, it should be clear that a variation that may be currently known or later developed or later made possible by advances in technology also is within the scope of the appended claims and is contemplated by and within the spirit of the detailed disclosure.